Conflict of interest: Honoraria for lectures from Bristol Myers Squibb, sanofi-aventis, Eli Lilly and Co., and Daiichi Sankyo, Inc; Astra Zeneca; consulting fees from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly and Co., Daiichi Sankyo, Inc., The Medicines Company, Portola, Novartis, Medicure, Accumetrics, Arena Pharmaceuticals, Merck, Abbott Vascular, and Astra Zeneca; and research grants from Bristol Myers Squibb, sanofi-aventis, GlaxoSmithKline, Otsuka, Eli Lilly and Co., Daiichi Sankyo, Inc., The Medicines Company, Portola, Accumetrics, Schering-Plough, Astra Zeneca, Eisai, and Johnson and Johnson (D.J.A.); Honoraria for lectures from Eli Lilly and Co., and Daiichi Sankyo, Inc. (T.A.B); Honoraria for lectures from Abbott, Bristol Myers Squibb, sanofi-aventis, Eli Lilly and Co., and Daiichi Sankyo, Inc, Pfizer; and research grants from Millenium and Astellas (M.Z.Z.); Honoraria for lectures from Daiichi Sankyo, Inc.; Eli Lilly Co. (J.L.F.).
Coronary Artery Disease
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status†
Article first published online: 17 APR 2012
Copyright © 2012 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 81, Issue 1, pages 42–49, 1 January 2013
How to Cite
Capranzano, P., Ferreiro, J. L., Ueno, M., Capodanno, D., Dharmashankar, K., Darlington, A., Desai, B., Tello-Montoliu, A., Rollini, F. and Angiolillo, D. J. (2013), Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status. Cathet. Cardiovasc. Intervent., 81: 42–49. doi: 10.1002/ccd.24416
- Issue published online: 21 DEC 2012
- Article first published online: 17 APR 2012
- Accepted manuscript online: 19 MAR 2012 11:35AM EST
- Manuscript Accepted: 10 MAR 2012
- Manuscript Revised: 16 FEB 2012
- Manuscript Received: 28 JAN 2012
- Dominick J Angiolillo was recipient of the 2007 GlaxoSmithKline International Competitive Grant Award for Young Investigators (GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease)
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.